article thumbnail

COVID-19 Vaccines with Dr. Forest Arnold

Louisville Lectures

Forest Arnold returns to present "COVID-19 Vaccines: Wows and Woes" today on Louisville Lectures. In this presentation, Dr. Arnold gives an overview of COVID-19 and vaccines. After, he presents the CDC Advisory Committee on Immunization Practices and the efficacy of vaccines in light of variants. Arnold, D.O., FIDSA Forest W.

article thumbnail

HPV Vaccine Secondary Acceptance: Turning No into a Yes! [Child and adolescent health]

Annals of Family Medicine

Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Frailty Triples Odds of More Severe RSV Illness

Physician's Weekly

Data came from the three influenza seasons from 2012 to 2015. Most patients (71.0%) had received the current season’s RSV vaccine. Melissa Andrew, MD, PhD , and colleagues assessed data from a severe outcomes surveillance network housed within a larger immunization research network. Additionally, 63.8% of the patients were women.

Illness 52
article thumbnail

FDA’s Accelerated Approval of Biogen’s Aduhelm for Alzheimer’s: A Sign of Applying the Emergency Use Standard Beyond COVID?

FDA Law Blog

However, the FDA guidance goes on to say in some cases, additional context is needed by specifically inserting a sentence in the indications statement that: no clinical benefit has been established. be “reasonably likely to predict” ultimate clinical benefit).

Clinic 98
article thumbnail

COVID-19 (SARS-CoV-2) Epidemic with Dr. Forest Arnold

Louisville Lectures

" COVID-19 Vaccines: Wows and Woes " The mentioned SARS-CoV-2 is in reference to COVID-19 Dr. Forest Arnold's focuses on summarizing the extent of human coronaviruses, risk factors, and the clinical presentation of patients with coronavirus to the extent known. Disclaimers ©2015 LouisvilleLectures.org Arnold, D.O.,

article thumbnail

COVID-19: An Update with Dr. Mark Burns

Louisville Lectures

After, he explains the clinical presentation and current commendations for pharmacologic management and finally, the vaccines in phase 3 trials. His clinical expertise is in Infectious Diseases and he is board certified on the American Board of Internal Medicine - Infectious Diseases. Disclaimers ©2015 LouisvilleLectures.org

article thumbnail

This Holiday Season

Louisville Lectures

The Pfizer-BioNTech COVID-19 Vaccine Learn more Our COVID-19 Little Lectures COVID-19 (Part One) with Dr. Laura Bishop Dr. Laura Bishop presents the COVID-19 Series. Disclaimers ©2015 LouisvilleLectures.org Stay #healthyathome and follow CDC guidelines for how to protect you and your loved ones.